Effects of ex vivo transduction of mesencephalic reaggregates with bcl-2 on grafted dopamine neuron survival
- PMID: 17196186
- PMCID: PMC2041451
- DOI: 10.1016/j.brainres.2006.11.079
Effects of ex vivo transduction of mesencephalic reaggregates with bcl-2 on grafted dopamine neuron survival
Abstract
Survival rates of dopamine (DA) neurons grafted to the denervated striatum are extremely poor (5-20%). Gene transfer of survival promoting factors, such as the anti-apoptotic protein bcl-2, to mesencephalic DA neurons prior to transplantation (ex vivo transduction) offers a novel approach to increase graft survival. However, specific criteria to assess the efficacy of various vectors must be adhered to in order to reasonably predict successful gene transfer with appropriate timing and levels of protein expression. Cell culture results utilizing three different herpes simplex virus (HSV) vectors to deliver the reporter beta-galactosidase gene (lacZ) indicate that transduction of mesencephalic cells with a helper virus-free HSV amplicon (HF HSV-TH9lac) that harbors the 9-kb tyrosine hydroxylase (TH) promoter to drive lacZ gene expression elicits the transduction of the highest percentage (approximately 50%) of TH-immunoreactive (THir) neurons without significant cytotoxic effects. This transduction efficiency and limited cytotoxicity was superior to that observed following transduction with helper virus-containing HSV (HC HSVlac) and helper virus-free HSV amplicons (HF HSVlac) expressing lacZ under the transcriptional control of the HSV immediate-early 4/5 gene promoter. Subsequently, we assessed the ability of HSV-TH9lac and the bcl-2 expressing HSV-TH9bcl-2 amplicon to transduce mesencephalic reaggregates. Although an increase in bcl-2 and beta-galactosidase protein was induced by transduction, amplicon-mediated overexpression of bcl-2 did not lead to an increase in grafted THir neuron number. Even with highly efficient viral vector-mediated transduction, our results demonstrate that ex vivo gene transfer of bcl-2 to mesencephalic reaggregates is ineffective in increasing grafted DA neuron survival.
Figures





Similar articles
-
An in vitro interval before transplantation of mesencephalic reaggregates does not compromise survival or functionality.Exp Neurol. 2004 May;187(1):58-64. doi: 10.1016/j.expneurol.2003.12.008. Exp Neurol. 2004. PMID: 15081588
-
Increased cell suspension concentration augments the survival rate of grafted tyrosine hydroxylase immunoreactive neurons.J Neurosci Methods. 2007 Oct 15;166(1):13-9. doi: 10.1016/j.jneumeth.2007.06.022. Epub 2007 Jul 1. J Neurosci Methods. 2007. PMID: 17706789 Free PMC article.
-
Diminished survival of mesencephalic dopamine neurons grafted into aged hosts occurs during the immediate postgrafting interval.Exp Neurol. 2001 May;169(1):23-9. doi: 10.1006/exnr.2001.7644. Exp Neurol. 2001. PMID: 11312554
-
Strategies for the augmentation of grafted dopamine neuron survival.Front Biosci. 2003 May 1;8:s522-32. doi: 10.2741/1096. Front Biosci. 2003. PMID: 12700087 Review.
-
CNS immunological modulation of neural graft rejection and survival.Neurol Res. 1996 Aug;18(4):297-304. doi: 10.1080/01616412.1996.11740425. Neurol Res. 1996. PMID: 8875445 Review.
Cited by
-
Effects of herpes simplex virus amplicon transduction on murine dendritic cells.Hum Gene Ther. 2009 May;20(5):442-52. doi: 10.1089/hum.2008.160. Hum Gene Ther. 2009. PMID: 19199821 Free PMC article.
-
An integral approach to the etiopathogenesis of human neurodegenerative diseases (HNDDs) and cancer. Possible therapeutic consequences within the frame of the trophic factor withdrawal syndrome (TFWS).Neuropsychiatr Dis Treat. 2008 Dec;4(6):1073-84. doi: 10.2147/ndt.s3800. Neuropsychiatr Dis Treat. 2008. PMID: 19337452 Free PMC article.
-
How to improve the survival of the fetal ventral mesencephalic cell transplanted in Parkinson's disease?Neurosci Bull. 2007 Nov;23(6):377-82. doi: 10.1007/s12264-007-0056-4. Neurosci Bull. 2007. PMID: 18064069 Free PMC article. Review.
-
Ion channels in regulation of neuronal regenerative activities.Transl Stroke Res. 2014 Feb;5(1):156-62. doi: 10.1007/s12975-013-0320-z. Epub 2014 Jan 8. Transl Stroke Res. 2014. PMID: 24399572 Free PMC article. Review.
References
-
- Abercrombie M. Estimation of nuclear populations from microtome sections. Anat Rec. 1946;94:239–247. - PubMed
-
- Anton R, Kordower JH, Kane DJ, Markham CH, Bredesen Neural transplantation of cells expressing the anti-apoptotic gene bcl-2. Cell Transplant. 1995;4:49–54. D.E. - PubMed
-
- Bankiewicz KS, Leff SE, Nagy D, Jungles S, Rokovich J, Spratt K, Cohen L, Libonati M, Snyder RO, Mandel RJ. Practical aspects of the development of ex vivo and in vivo gene therapy for Parkinson's disease. Exp Neurol. 1997;144:147–156. - PubMed
-
- Barker RA, Dunnett SB, Faissner A, Fawcett JW. The time course of cell loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum. Exp Neurol. 1996;141:79–93. - PubMed
-
- Bowers WJ, Howard DF, Federoff HJ. Discordance between expression and genome transfer titering of HSV amplicon vectors: recommendation for standardized enumeration. Mol Ther. 2000;1(3):294–299. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous